The forecast for Brazil's imports of vaccines for human use indicates a steady increase from 2024 to 2028, with volumes rising from 1.1787 million kilograms in 2024 to 1.2949 million kilograms in 2028. This represents a compound annual growth rate (CAGR) of approximately 2.38% over the five-year period. When compared to the 1.15 million kilograms imported in 2023, the growth highlights an enhanced demand driven by healthcare expansion and vaccination efforts.
In the coming years, several trends should be monitored:
- Global vaccine supply chain dynamics
- Potential shifts in Brazil's domestic vaccine production capacity
- Policy changes impacting health funding and import regulations
